Maravai LifeSciences Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bernd Brust, with a market cap of $538.7M.
Common questions about Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $53.0M.
Maravai LifeSciences Holdings, Inc. has approximately 570 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.